Showing results (61-70 of 76) with videos related to
Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2016
Suramin inhibits cullin-RING E3 ubiquitin ligasesKenneth Wu, Robert A Chong, Qing Yu, et al.Proceedings of the National Academy of Sciences of the United States of America|June 10, 2014
Pivotal role for the ubiquitin Y59-E51 loop in lysine 48 polyubiquitinationRobert A Chong, Kenneth Wu, Donald E Spratt, et al.The Journal of Biological Chemistry|June 3, 2005
(D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-GAndrew K P Taggart, Jukka Kero, Xiaodong Gan, et al.Nature Cardiovascular Research|August 28, 2024
Functional analysis of a common BAG3 allele associated with protection from heart failureJuan A Perez-Bermejo, Luke M Judge, Christina L Jensen, et al.Blood Advances|August 19, 2025
Zanubrutinib in the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studiesConstantine S Tam, Mary Ann Anderson, Martin Simkovic, et al.Annals of Hematology|June 18, 2024
Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINEKeshu Zhou, Tingyu Wang, Ling Pan, et al.Nature Genetics|August 2, 2019
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genesMichael Song, Xiaoyu Yang, Xingjie Ren, et al.Blood|September 24, 2024
Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINEJennifer R Brown, Barbara Eichhorst, Nicole Lamanna, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2022
Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III TrialPeter Hillmen, Barbara Eichhorst, Jennifer R Brown, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Neoadjuvant Enzalutamide Prior to ProstatectomyBruce Montgomery, Maria S Tretiakova, Anthony M Joshua, et al.Pageof 8